The modular Fee-For-Service business model

Innovagen provides a range of custom services when it comes to antibody development, as well as protein production and peptide synthesis. We have the same Fee-For-Service business model for all these services, whether it concerns the synthesis of a single peptide or an antibody humanisation project. This means that Innovagen will only charge you for the actual services that have been carried out. There are no licence fees or royalties due to us, and you are the sole owner of and holder of all rights to the materials that are produced, such as a cell line, cDNA antibody sequence, or a custom synthetic peptide.

For the larger projects, such as monoclonal antibody development, the services are modular. This means that you have the opportunity to evaluate the progress after each step in the process, and the following step in the project is then entered into only after your explicit confirmation. Thus, you can initiate a larger project while only committing to the first step.

Since 1992, Innovagen has been providing the scientific community with research materials. Our experience, dedication to quality and excellent customer service will give you the best conditions for a successful outcome of your research project.